Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis

Epirubicin (EPI) is one of the most used intravesical chemotherapy agents after transurethral resection to non-muscle invasive bladder tumors (NMIBC) to prevent cancer recurrence and progression. However, even after resection of bladder tumors and intravesical chemotherapy, half of them will recur a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jun-Feng, Yu, Bi-Xia, Yu, Rui, Ma, Liang, Lv, Xiu-Yi, Cheng, Yue, Ma, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355669/
https://www.ncbi.nlm.nih.gov/pubmed/28075465
http://dx.doi.org/10.3892/or.2017.5356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355669/
https://www.ncbi.nlm.nih.gov/pubmed/28075465
http://dx.doi.org/10.3892/or.2017.5356

Ejemplares similares